1
|
Chontzopoulou E, Tzakos AG, Mavromoustakos T. On the Rational Drug Design for Hypertension through NMR Spectroscopy. Molecules 2020; 26:E12. [PMID: 33375119 PMCID: PMC7792925 DOI: 10.3390/molecules26010012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2020] [Revised: 12/18/2020] [Accepted: 12/21/2020] [Indexed: 12/19/2022] Open
Abstract
Antagonists of the AT1receptor (AT1R) are beneficial molecules that can prevent the peptide hormone angiotensin II from binding and activating the specific receptor causing hypertension in pathological states. This review article summarizes the multifaced applications of solid and liquid state high resolution nuclear magnetic resonance (NMR) spectroscopy in antihypertensive commercial drugs that act as AT1R antagonists. The 3D architecture of these compounds is explored through 2D NOESY spectroscopy and their interactions with micelles and lipid bilayers are described using solid state 13CP/MAS, 31P and 2H static solid state NMR spectroscopy. Due to their hydrophobic character, AT1R antagonists do not exert their optimum profile on the AT1R. Therefore, various vehicles are explored so as to effectively deliver these molecules to the site of action and to enhance their pharmaceutical efficacy. Cyclodextrins and polymers comprise successful examples of effective drug delivery vehicles, widely used for the delivery of hydrophobic drugs to the active site of the receptor. High resolution NMR spectroscopy provides valuable information on the physical-chemical forces that govern these drug:vehicle interactions, knowledge required to get a deeper understanding on the stability of the formed complexes and therefore the appropriateness and usefulness of the drug delivery system. In addition, it provides valuable information on the rational design towards the synthesis of more stable and efficient drug formulations.
Collapse
Affiliation(s)
- Eleni Chontzopoulou
- Department of Chemistry, National and Kapodistrian University of Athens, 15784 Athens, Greece;
| | - Andreas G. Tzakos
- Department of Chemistry, Section of Organic Chemistry and Biochemistry, University of Ioannina, 45110 Ioannina, Greece;
| | - Thomas Mavromoustakos
- Department of Chemistry, National and Kapodistrian University of Athens, 15784 Athens, Greece;
| |
Collapse
|
2
|
Insights into the molecular basis of action of the AT1 antagonist losartan using a combined NMR spectroscopy and computational approach. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES 2013; 1838:1031-46. [PMID: 24374319 DOI: 10.1016/j.bbamem.2013.12.012] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/12/2013] [Revised: 12/17/2013] [Accepted: 12/19/2013] [Indexed: 01/11/2023]
Abstract
The drug:membrane interactions for the antihypertensive AT1 antagonist losartan, the prototype of the sartans class, are studied herein using an integrated approach. The pharmacophore arrangement of the drug was revealed by rotating frame nuclear Overhauser effect spectroscopy (2D ROESY) NMR spectroscopy in three different environments, namely water, dimethyl sulfoxide (DMSO), and sodium dodecyl sulfate (SDS) micellar solutions mimicking conditions of biological transport fluids and membrane lipid bilayers. Drug association with micelles was monitored by diffusion ordered spectroscopy (2D DOSY) and drug:micelle intermolecular interactions were characterized by ROESY spectroscopy. The localisation of the drug in the micellar environment was investigated by introducing 5-doxyl and 16-doxyl stearic acids. The use of spin labels confirmed that losartan resides close to the micelle:water interface with the hydroxymethyl group and the tetrazole heterocyclic aromatic ring facing the polar surface with the potential to interact with SDS charged polar head groups in order to increase amphiphilic interactions. The spontaneous insertion, the diffusion pathway and the conformational features of losartan were monitored by Molecular Dynamics (MD) simulations in a modeled SDS micellar aggregate environment and a long exploratory MD run (580ns) in a phospholipid dipalmitoylphosphatidylcholine (DPPC) bilayer with the AT1 receptor embedded. MD simulations were in excellent agreement with experimental results and further revealed the molecular basis of losartan:membrane interactions in atomic-level detail. This applied integrated approach aims to explore the role of membranes in losartan's pathway towards the AT1 receptor.
Collapse
|
3
|
Agelis G, Resvani A, Ntountaniotis D, Chatzigeorgiou P, Koukoulitsa C, Androutsou ME, Plotas P, Matsoukas J, Mavromoustakos T, Cendak T, Godec TU, Mali G. Interactions of the potent synthetic AT1 antagonist analog BV6 with membrane bilayers and mesoporous silicate matrices. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES 2013; 1828:1846-55. [PMID: 23506680 DOI: 10.1016/j.bbamem.2013.03.009] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/21/2012] [Revised: 03/06/2013] [Accepted: 03/08/2013] [Indexed: 11/27/2022]
Abstract
The present work describes the drug:membrane interactions and a drug delivery system of the novel potent AT1 blocker BV6. This designed analog has most of the pharmacological segments of losartan and an additional biphenyltetrazole moiety resulting in increased lipophilicity. We found that BV6:membrane interactions lead to compact bilayers that may in part explain its higher in vitro activity compared to losartan since such environment may facilitate its approach to AT1 receptor. Its high docking score to AT1 receptor stems from more hydrophobic interactions compared to losartan. X-ray powder diffraction (XRPD) and thermogravimetric analysis (TGA) have shown that BV6 has a crystalline form that is not decomposed completely up to 600°C. These properties are desirable for a drug molecule. BV6 can also be incorporated into a mesoporous silicate drug-delivery matrix SBA-15. The properties of the obtained drug-delivery system have been inspected by XRD, (13)C CP/MAS, TGA and nitrogen sorption experiments.
Collapse
Affiliation(s)
- G Agelis
- Eldrug S.A., Patras Science Park, Stadiou, Platani, Rio Patras, Greece
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Molecular insights into the AT1 antagonism based on biophysical and in silico studies of telmisartan. Med Chem Res 2013. [DOI: 10.1007/s00044-012-0464-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
5
|
Fotakis C, Megariotis G, Christodouleas D, Kritsi E, Zoumpoulakis P, Ntountaniotis D, Zervou M, Potamitis C, Hodzic A, Pabst G, Rappolt M, Mali G, Baldus J, Glaubitz C, Papadopoulos MG, Afantitis A, Melagraki G, Mavromoustakos T. Comparative study of the AT1 receptor prodrug antagonist candesartan cilexetil with other sartans on the interactions with membrane bilayers. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES 2012; 1818:3107-20. [DOI: 10.1016/j.bbamem.2012.08.009] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/22/2012] [Revised: 07/26/2012] [Accepted: 08/13/2012] [Indexed: 11/28/2022]
|
6
|
Hodzic A, Zoumpoulakis P, Pabst G, Mavromoustakos T, Rappolt M. Losartan's affinity to fluid bilayers modulates lipid-cholesterol interactions. Phys Chem Chem Phys 2012; 14:4780-8. [PMID: 22395854 DOI: 10.1039/c2cp40134g] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Losartan is an angiotensin II receptor antagonist mainly used for the regulation of high blood pressure. Since it was anticipated that losartan reaches the receptor site via membrane diffusion, the impact of losartan on model membranes has been investigated by small angle X-ray scattering. For this purpose 2-20 mol% losartan was incorporated into dimyristoyl-phosphatidylcholine (DMPC) and palmitoyl-oleoyl-phosphatidylcholine (POPC) bilayers and into their binary mixtures with cholesterol in the concentration range of 0 to 40 mol%. Effects of losartan on single component bilayers are alike. Partitioning of losartan into the membranes confers a negative charge to the lipid bilayers that causes the formation of unilamellar vesicles and a reduction of the bilayer thickness by 3-4%. Analysis of the structural data resulted in an estimate for the partial area of losartan, A(Los) ≈ 40 Å(2). In the presence of cholesterol, differences between the effects of losartan on POPC and DMPC are striking. Membrane condensation by cholesterol is retarded by losartan in POPC. This contrasts with DMPC, where an increase of the cholesterol content shifts the partitioning equilibrium of losartan towards the aqueous phase, such that losartan gets depleted from the bilayers from 20 mol% cholesterol onwards. This indicates (i) a chain-saturation dependent competition of losartan with lipid-cholesterol interactions, and (ii) the insolubility of losartan in the liquid ordered phase of PCs. Consequently, losartan's action is more likely to take place in fluid plasma membrane patches rather than in domains rich in cholesterol and saturated lipid species such as in membrane rafts.
Collapse
Affiliation(s)
- A Hodzic
- Institute of Biophysics and Nanosystems Research, Austrian Academy of Science, 8042 Graz, Austria
| | | | | | | | | |
Collapse
|
7
|
Ntountaniotis D, Mali G, Grdadolnik SG, Halabalaki M, Maria H, Skaltsounis AL, Potamitis C, Siapi E, Chatzigeorgiou P, Rappolt M, Mavromoustakos T. Thermal, dynamic and structural properties of drug AT1 antagonist olmesartan in lipid bilayers. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES 2011; 1808:2995-3006. [PMID: 21843501 DOI: 10.1016/j.bbamem.2011.08.001] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/26/2011] [Revised: 07/14/2011] [Accepted: 08/01/2011] [Indexed: 01/13/2023]
Abstract
It is proposed that AT1 antagonists (ARBs) exert their biological action by inserting into the lipid membrane and then diffuse to the active site of AT1 receptor. Thus, lipid bilayers are expected to be actively involved and play a critical role in drug action. For this reason, the thermal, dynamic and structural effects of olmesartan alone and together with cholesterol were studied using differential scanning calorimetry (DSC), 13C magic-angle spinning (MAS) nuclear magnetic resonance (NMR), cross-polarization (CP) MAS NMR, and Raman spectroscopy as well as small- and wide angle X-ray scattering (SAXS and WAXS) on dipalmitoyl-phosphatidylcholine (DPPC) multilamellar vesicles. 13C CP/MAS spectra provided direct evidence for the incorporation of olmesartan and cholesterol in lipid bilayers. Raman and X-ray data revealed how both molecules modify the bilayer's properties. Olmesartan locates itself at the head-group region and upper segment of the lipid bilayers as 13C CP/MAS spectra show that its presence causes significant chemical shift changes mainly in the A ring of the steroidal part of cholesterol. The influence of olmesartan on DPPC/cholesterol bilayers is less pronounced. Although, olmesartan and cholesterol are residing at the same region of the lipid bilayers, due to their different sizes, display distinct impacts on the bilayer's properties. Cholesterol broadens significantly the main transition, abolishes the pre-transition, and decreases the membrane fluidity above the main transition. Olmesartan is the only so far studied ARB that increases the gauche:trans ratio in the liquid crystalline phase. These significant differences of olmesartan may in part explain its distinct pharmacological profile.
Collapse
|
8
|
Potamitis C, Chatzigeorgiou P, Siapi E, Viras K, Mavromoustakos T, Hodzic A, Pabst G, Cacho-Nerin F, Laggner P, Rappolt M. Interactions of the AT1 antagonist valsartan with dipalmitoyl-phosphatidylcholine bilayers. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES 2011; 1808:1753-63. [DOI: 10.1016/j.bbamem.2011.02.002] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/22/2010] [Revised: 01/30/2011] [Accepted: 02/01/2011] [Indexed: 11/16/2022]
|
9
|
Fotakis C, Christodouleas D, Zoumpoulakis P, Kritsi E, Benetis NP, Mavromoustakos T, Reis H, Gili A, Papadopoulos MG, Zervou M. Comparative Biophysical Studies of Sartan Class Drug Molecules Losartan and Candesartan (CV-11974) with Membrane Bilayers. J Phys Chem B 2011; 115:6180-92. [DOI: 10.1021/jp110371k] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Charalambos Fotakis
- Institute of Organic and Pharmaceutical Chemistry, National Hellenic Research Foundation, Vas. Constantinou 48, Athens 11635, Greece
- Chemistry Department, National and Kapodistrian University of Athens, Panepistimiopolis Zographou 15771, Greece
| | - Dionysios Christodouleas
- Institute of Organic and Pharmaceutical Chemistry, National Hellenic Research Foundation, Vas. Constantinou 48, Athens 11635, Greece
- Chemistry Department, National and Kapodistrian University of Athens, Panepistimiopolis Zographou 15771, Greece
| | - Panagiotis Zoumpoulakis
- Institute of Organic and Pharmaceutical Chemistry, National Hellenic Research Foundation, Vas. Constantinou 48, Athens 11635, Greece
| | - Eftichia Kritsi
- Institute of Organic and Pharmaceutical Chemistry, National Hellenic Research Foundation, Vas. Constantinou 48, Athens 11635, Greece
- Chemistry Department, National and Kapodistrian University of Athens, Panepistimiopolis Zographou 15771, Greece
| | - Nikolas-Ploutarch Benetis
- Institute of Organic and Pharmaceutical Chemistry, National Hellenic Research Foundation, Vas. Constantinou 48, Athens 11635, Greece
| | - Thomas Mavromoustakos
- Institute of Organic and Pharmaceutical Chemistry, National Hellenic Research Foundation, Vas. Constantinou 48, Athens 11635, Greece
- Chemistry Department, National and Kapodistrian University of Athens, Panepistimiopolis Zographou 15771, Greece
| | - Heribert Reis
- Institute of Organic and Pharmaceutical Chemistry, National Hellenic Research Foundation, Vas. Constantinou 48, Athens 11635, Greece
| | - Argiro Gili
- Institute of Organic and Pharmaceutical Chemistry, National Hellenic Research Foundation, Vas. Constantinou 48, Athens 11635, Greece
- School of Applied Mathematical and Physical Science, National Technical University of Athens, Zographou Campus, 15700 Athens, Greece
| | - Manthos G. Papadopoulos
- Institute of Organic and Pharmaceutical Chemistry, National Hellenic Research Foundation, Vas. Constantinou 48, Athens 11635, Greece
| | - Maria Zervou
- Institute of Organic and Pharmaceutical Chemistry, National Hellenic Research Foundation, Vas. Constantinou 48, Athens 11635, Greece
| |
Collapse
|
10
|
Chatzigeorgiou P, Papakonstantopoulos N, Tagaroulia N, Pollatos E, Xynogalas P, Viras K. Solid-solid phase transitions in DL-norvaline studied by differential scanning calorimetry and Raman spectroscopy. J Phys Chem B 2010; 114:1294-300. [PMID: 20043648 DOI: 10.1021/jp9096106] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The structural modifications of the amino acid DL-Norvaline have been studied using differential scanning calorimetry (DSC) and Raman spectroscopy. DSC results showed that this amino acid undergoes two solid-solid phase transitions at -116.9 and -76.1 degrees C in the temperature range -130 to +300 degrees C. Raman spectroscopy was applied to complement DSC results. The combination of the two methodologies point out that the observed phase transitions correspond to an increment of disordering in the aliphatic side chain of amino acid, an augmentation of the rotational motion of the amino group and a decrease of the strength of the intramolecular hydrogen bonding of the initial dimers at low temperatures. The observed phase transitions of DL-norvaline are compared with those found in DL-norleucine.
Collapse
Affiliation(s)
- Petros Chatzigeorgiou
- Chemistry Department, Laboratory of Physical Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, Athens 157 71, Greece.
| | | | | | | | | | | |
Collapse
|